Iron deficiency is a key determinant of health-related quality of life in patients with chronic heart failure regardless of anaemia status

European Journal of Heart Failure

Volumn 15, Issue 10, 2013, Pages 1164-1172

  Comín Colet, Josep ^a,b   Enjuanes, Cristina ^a,b   González, Gina ^a,c   Torrens, Ainhoa ^a,b   Cladellas, Mercè ^a,b   Meroño, Oona ^a,b   Ribas, Nuria ^a,b   Ruiz, Sonia ^a   Gómez, Miquel ^a,b   Verdú, José Maria ^a,b,d   Bruguera, Jordi ^a  

^a HOSPITAL DEL MAR   (Spain)

^b UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^c Fundacion Santa Fe   (Colombia)

^d Catalan Institut of Oncology   (Spain)

Author keywords

Anaemia; Health related quality of life; Iron deficiency

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; C REACTIVE PROTEIN; FERRITIN; HEMOGLOBIN; IRON; TRANSFERRIN; TRANSFERRIN RECEPTOR;

ADULT; AGED; ARTICLE; BLOOD SAMPLING; FEMALE; FERRITIN BLOOD LEVEL; GLOMERULUS FILTRATION RATE; HEART FAILURE; HUMAN; IRON BLOOD LEVEL; IRON DEFICIENCY; MAJOR CLINICAL STUDY; MALE; MORBIDITY; POST HOC ANALYSIS; PRIORITY JOURNAL; QUALITY OF LIFE; SEROLOGY; TRANSFERRIN BLOOD LEVEL;

ANAEMIA; HEALTH-RELATED QUALITY OF LIFE; IRON DEFICIENCY;

AGED; AGED, 80 AND OVER; ANEMIA, IRON-DEFICIENCY; CASE-CONTROL STUDIES; CHRONIC DISEASE; EXERCISE TOLERANCE; FATIGUE; FEMALE; FERRITINS; HEALTH STATUS; HEART FAILURE; HUMANS; IRON; LOGISTIC MODELS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; QUALITY OF LIFE; RISK FACTORS; SEVERITY OF ILLNESS INDEX; TRANSFERRIN;

EID: 84884553015     PISSN: 13889842     EISSN: 18790844     Source Type: Journal    
DOI: 10.1093/eurjhf/hft083     Document Type: Article

References (23)

1. Calvert MJ, Freemantle N, Cleland JG. The impact of chronic heart failure on health-related quality of life data acquired in the baseline phase of the CARE-HF study. Eur J Heart Fail 2005;7:243-251. (Pubitemid 40215620)
2. Juenger J, Schellberg D, Kraemer S, Haunstetter A, Zugck C, Herzog W, Haass M. Health related quality of life in patients with congestive heart failure: comparison with other chronic diseases and relation to functional variables. Heart 2002;87: 235-241. (Pubitemid 34177677)
3. Jaarsma T, Beattie JM, Ryder M, Rutten FH, McDonagh T, Mohacsi P, Murray SA, Grodzicki T, Bergh I, Metra M, Ekman I, Angermann C, Leventhal M, Pitsis A, Anker SD, Gavazzi A, Ponikowski P, Dickstein K, Delacretaz E, Blue L, Strasser F, McMurray J. Palliative care in heart failure: a position statement from the palliative care workshop of the Heart Failure Association of the European Society of Cardiology. Eur J Heart Fail 2009;11:433-443.
4. Comin-Colet J, Garin O, Lupon J, Manito N, Crespo-Leiro MG, Gomez-Bueno M, Ferrer M, Artigas R, Zapata A, Elosua R. Validation of the Spanish version of the Kansas City Cardiomyopathy Questionnaire. Rev Esp Cardiol 2011;64:51-58.
5. Myers J, Zaheer N, Quaglietti S, Madhavan R, Froelicher V, Heidenreich P. Association of functional and health status measures in heart failure. J Card Fail 2006;12: 439-445. (Pubitemid 46106981)
6. Jankowska EA, Rozentryt P, Witkowska A, Nowak J, Hartmann O, Ponikowska B, Borodulin-Nadzieja L, Banasiak W, Polonski L, Filippatos G, McMurray JJ, Anker SD, Ponikowski P. Iron deficiency: an ominous sign in patients with systolic chronic heart failure. Eur Heart J 2010;31:1872-1880.
7. Parikh A, Natarajan S, Lipsitz SR, Katz SD. Iron deficiency in community-dwelling US adults with self-reported heart failure in the National Health and Nutrition Examination Survey III: prevalence and associations with anemia and inflammation. Circ Heart Fail 2011;4:599-606.
8. Jankowska EA, Rozentryt P, Witkowska A, Nowak J, Hartmann O, Ponikowska B, Borodulin-Nadzieja L, von Haehling S, Doehner W, Banasiak W, Polonski L, Filippatos G, Anker SD, Ponikowski P. Iron deficiency predicts impaired exercise capacity in patients with systolic chronic heart failure. J Card Fail 2011;17:899-906.
9. Brownlie TT, Utermohlen V, Hinton PS, Haas JD. Tissue iron deficiency without anemia impairs adaptation in endurance capacity after aerobic training in previously untrained women. Am J Clin Nutr 2004;79:437-443. (Pubitemid 41115588)
10. Anker SD, Comin Colet J, Filippatos G, Willenheimer R, Dickstein K, Drexler H, Luscher TF, Bart B, Banasiak W, Niegowska J, Kirwan BA, Mori C, von Eisenhart Rothe B, Pocock SJ, Poole-Wilson PA, Ponikowski P. Ferric carboxymaltose in patients with heart failure and iron deficiency. N Engl J Med 2009;361:2436-2448.
11. Toblli JE, Lombrana A, Duarte P, Di Gennaro F. Intravenous iron reduces NT-pro-brain natriuretic peptide in anemic patients with chronic heart failure and renal insufficiency. J Am Coll Cardiol 2007;50:1657-1665. (Pubitemid 47562670)
12. Comin-Colet J, Lainscak M, Dickstein K, Filippatos GS, Johnson P, Luscher TF,MoriC, Willenheimer R, Ponikowski P, Anker SD. The effect of intravenous ferric carboxymaltose on health-related quality of life in patients with chronic heart failure and iron deficiency: a subanalysis of the FAIR-HF study. Eur Heart J 2013;34:30-38.
13. KDOQI. KDOQI clinical practice guideline and clinical practice recommendations for anemia in chronic kidney disease: 2007 update of hemoglobin target. Am J Kidney Dis 2007;50:471-530.
14. WuA. Tietz Clinical Guide to Laboratory Tests. 4th ed. St Louis, MO: Saunders Elsevier; 2006. p56-61.
15. Garin O, Soriano N, Ribera A, Ferrer M, Pont A, Alonso J, Permanyer G. [Validation of the Spanish version of the Minnesota Living with Heart Failure Questionnaire]. Rev Esp Cardiol 2008;61:251-259. (Pubitemid 351928298)
16. Haas JD, Brownlie T 4th. Iron deficiency and reduced work capacity: a critical review of the research to determine a causal relationship. J Nutr 2001;131:676S-688S; discussion 688S-690S.
17. Jankowska EA, Ponikowski P. Molecular changes in myocardium in the course of anemia or iron deficiency. Heart Fail Clin 2010;6:295-304.
18. Maeder MT, Khammy O, dos Remedios C, Kaye DM. Myocardial and systemic iron depletion in heart failure implications for anemia accompanying heart failure. J Am Coll Cardiol 2011;58:474-480.
19. Macdougall IC, Canaud B, de Francisco AL, Filippatos G, Ponikowski P, Silverberg D, van Veldhuisen DJ, Anker SD. Beyond the cardiorenal anaemia syndrome: recognizing the role of iron deficiency. Eur J Heart Fail 2012;14:882-886.
20. AvniT, Leibovici L, Gafter-Gvili A. Iron supplementation for the treatmentof chronic heart failure and iron deficiency: systematic review and meta-analysis. Eur J Heart Fail 2012;14:423-429
21. Cullis JO. Diagnosis and management of anaemia of chronic disease: current status. Br J Haematol 2011;154:289-300.
22. Suominen P, Mottonen T, Rajamaki A, Irjala K. Single values of serum transferrin receptor and transferrin receptor ferritin index can be used to detect true and functional iron deficiency in rheumatoid arthritis patients with anemia. Arthritis Rheum 2000;43:1016-1020. (Pubitemid 30368178)
23. Suominen P, Punnonen K, RajamakiA, Irjala K. Serum transferrin receptor and transferrin receptor-ferritin index identify healthy subjects with subclinical iron deficits. Blood 1998;92:2934-2939. (Pubitemid 28469109)